These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 28844295)

  • 41. Infection-associated clozapine toxicity.
    Darling P; Huthwaite MA
    Clin Schizophr Relat Psychoses; 2011 Oct; 5(3):159-60. PubMed ID: 21983501
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical outcome and plasma levels of clozapine and norclozapine in drug-resistant schizophrenic patients.
    Mauri M; Volonteri LS; Fiorentini A; Invernizzi G; Nerini T; Baldi M; Bareggi SR
    Schizophr Res; 2004 Feb; 66(2-3):197-8. PubMed ID: 15061256
    [No Abstract]   [Full Text] [Related]  

  • 43. [Importance of determining clozapine plasma level in follow-up of schizophrenic patients].
    Vailleau JL; Jeanny B; Chomard P; Vincent R
    Encephale; 1996; 22(2):103-9. PubMed ID: 8706619
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuropsychological effects of maintenance treatment with Clozapine in Treatment-Resistant Psychotic Disorder.
    Carceller-Sindreu M; Portella MJ; Carmona C; Rametti G; Puigdemont D; Figueras M; Fernández-Vidal A; Villalta L; Alvarez E
    Actas Esp Psiquiatr; 2014; 42(2):68-73. PubMed ID: 24715364
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Determination of pharmacokinetic properties of clozapine and norclozapine in Korean schizophrenia patients.
    Lee ST; Ryu S; Nam HJ; Lee SY; Hong KS
    Int Clin Psychopharmacol; 2009 May; 24(3):139-44. PubMed ID: 19194306
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacoclinical strategy in neuroleptic resistant schizophrenic patients treated by clozapine: clinical evolution, concentration of plasma and red blood cell clozapine and desmethylclozapine, whole blood serotonin and tryptophan.
    Aymard N; Viala A; Baldacci C; Smagghe PO; Vacheron MN; Caroli F
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Jan; 23(1):25-41. PubMed ID: 10368854
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term therapeutic drug monitoring of clozapine and metabolites in psychiatric in- and outpatients.
    Dettling M; Sachse C; Brockmöller J; Schley J; Müller-Oerlinghausen B; Pickersgill I; Rolfs A; Schaub RT; Schmider J
    Psychopharmacology (Berl); 2000 Sep; 152(1):80-6. PubMed ID: 11041319
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Age and sex impact clozapine plasma concentrations in inpatients and outpatients with schizophrenia.
    Ismail Z; Wessels AM; Uchida H; Ng W; Mamo DC; Rajji TK; Pollock BG; Mulsant BH; Bies RR
    Am J Geriatr Psychiatry; 2012 Jan; 20(1):53-60. PubMed ID: 21422906
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma clozapine, norclozapine, and the clozapine:norclozapine ratio in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 1993-2007.
    Couchman L; Morgan PE; Spencer EP; Flanagan RJ
    Ther Drug Monit; 2010 Aug; 32(4):438-47. PubMed ID: 20463634
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clozapine, norclozapine plasma levels, their sum and ratio in 50 psychotic patients: influence of patient-related variables.
    Palego L; Biondi L; Giannaccini G; Sarno N; Elmi S; Ciapparelli A; Cassano GB; Lucacchini A; Martini C; Dell'Osso L
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Apr; 26(3):473-80. PubMed ID: 11999897
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Population pharmacokinetics of clozapine and its primary metabolite norclozapine in Chinese patients with schizophrenia.
    Li LJ; Shang DW; Li WB; Guo W; Wang XP; Ren YP; Li AN; Fu PX; Ji SM; Lu W; Wang CY
    Acta Pharmacol Sin; 2012 Nov; 33(11):1409-16. PubMed ID: 22820910
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Psychopharmacology. Clozapine and agranulocytosis.
    Feldman J
    Psychiatr Serv; 1996 Nov; 47(11):1177-8. PubMed ID: 8916231
    [No Abstract]   [Full Text] [Related]  

  • 53. Tolerability and efficacy of clozapine combined with lithium in schizophrenia and schizoaffective disorder.
    Small JG; Klapper MH; Malloy FW; Steadman TM
    J Clin Psychopharmacol; 2003 Jun; 23(3):223-8. PubMed ID: 12826983
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Blood biogenic amines during clozapine treatment of early-onset schizophrenia.
    Schulz E; Fleischhaker C; Clement HW; Remschmidt H
    J Neural Transm (Vienna); 1997; 104(10):1077-89. PubMed ID: 9503259
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prediction of working memory performance in schizophrenia by plasma ratio of clozapine to N-desmethylclozapine.
    Rajji TK; Mulsant BH; Davies S; Kalache SM; Tsoutsoulas C; Pollock BG; Remington G
    Am J Psychiatry; 2015 Jun; 172(6):579-85. PubMed ID: 25859763
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Higher plasma drug concentration in clozapine-treated schizophrenic patients with side effects of obsessive/compulsive symptoms.
    Lin SK; Su SF; Pan CH
    Ther Drug Monit; 2006 Jun; 28(3):303-7. PubMed ID: 16778711
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Factors associated with subjective side-effects during clozapine treatment.
    Seppälä N; Leinonen E; Viikki M; Solismaa A; Nuolivirta T; Kampman O
    Nord J Psychiatry; 2015 Apr; 69(3):161-6. PubMed ID: 25225739
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma amisulpride levels in schizophrenia or schizoaffective disorder.
    Bergemann N; Kopitz J; Kress KR; Frick A
    Eur Neuropsychopharmacol; 2004 May; 14(3):245-50. PubMed ID: 15056484
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gender, age, smoking behaviour and plasma clozapine concentrations in 193 Chinese inpatients with schizophrenia.
    Tang YL; Mao P; Li FM; Li W; Chen Q; Jiang F; Cai ZJ; Mitchell PB
    Br J Clin Pharmacol; 2007 Jul; 64(1):49-56. PubMed ID: 17298477
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Double-blind study of clozapine dose response in chronic schizophrenia.
    Simpson GM; Josiassen RC; Stanilla JK; de Leon J; Nair C; Abraham G; Odom-White A; Turner RM
    Am J Psychiatry; 1999 Nov; 156(11):1744-50. PubMed ID: 10553738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.